FDA Confirms One Dead After Massive Egg Recall
Per the FDA, the illness occurs within 12 to 72 hours after eating contaminated food, with symptoms lasting between four and seven days. Children, elderly, and the immunocompromised carry the biggest risk of severe reactions. Symptoms include fever, diarrhea, and stomach cramps.The outbreak spanned ten states and 134 people were confirmed to have been infected, resulting in 38 hospitalizations. The CDC declared that the outbreak has ended. At the time Men's Journal originally reported on the recall, 21 people had been hospitalized with no confirmed deaths. The FDA updated the initial recall statement on July 10.
At this point, all recalled eggs from August Egg Company have passed their expiration date and should not be on shelves. The company noted that this was a "voluntary recall" because Salmonella enteritidis "poses a health risk."
RELATED:
"It is important to know that when our processing plant identified this concern, we immediately began diverting all eggs from the plant to an egg-breaking facility, which pasteurizes the eggs and kills any pathogens," August Egg Company said in a statement on June 6. "August Egg Company's internal food safety team also is conducting its own stringent review to identify what measures can be established to prevent this situation from recurring."
The recall had spread to the states of Arizona, California, Colorado, Kansas, Kentucky, Nebraska, New Jersey, Nevada, Utah, and Washington.
There have been a slew of food recalls lately, as the FDA recently pulled chocolate products, water bottles sold at Walmart, and more than 367,000 pounds of Oscar Mayer turkey bacon off of shelves.FDA Confirms One Dead After Massive Egg Recall first appeared on Men's Journal on Jul 12, 2025
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Luigi Mangione prosecutors violating his health privacy rights, defense says
Defense attorneys for alleged UnitedHealthcare CEO shooter Luigi Mangione say prosecutors at the Manhattan district attorney's office are violating his health privacy rights by accessing confidential medical information, according to a court filing Thursday seeking a hearing and sanctions. "The District Attorney has subpoenaed Mr Mangione's health insurer, and, if their account is to be believed, they partially reviewed confidential, private, protected documents that the District Attorney readily admits are protected by the Health Insurance Portability and Accountability Act. There is no question that the District Attorney has no right to possess or review these documents," the filing said. MORE: Prosecutors trying to 'bias' the public against Luigi Mangione, defense says Mangione has pleaded not guilty to murdering UnitedHealthcare chief Brian Thompson on a Midtown street last December. Mangione was not covered by UnitedHealthcare. Instead, prosecutors have said he wanted to send a message about corporate greed. His attorneys are now seeking access to information from prosecutors and from Mangione's insurer, Aetna, arguing the subpoena was improper. "There is no question that the People have violated Mr Mangione's rights under HIPPA by possessing and reviewing the subpoenaed documents. However, the violation goes far beyond this. The violation also involves the intentional and knowing violating of his doctor-patient privilege," the defense said. MORE: Prosecutors detail how Luigi Mangione allegedly surveilled CEO: 'Checks every box' The district attorney's office said it will formally respond in court papers. However, prosecutors said they requested limited information from Aetna and Aetna sent them additional materials in error. Prosecutors said they deleted the materials as soon as they became aware of them and brought it to the attention of both the defense and the court. The error was compounded by defense counsel resending to prosecutors the very same items prosecutors had already deleted, a source familiar with the subpoena said. Solve the daily Crossword
Entrepreneur
7 minutes ago
- Entrepreneur
How 2 Stanford Grads Turned an Idea Into a WNBA Partnership
Amanda Calabrese and Greta Meyer turned a college project into Sequel, the first spiral tampon, now backed by a WNBA partnership with the Indiana Fever. Opinions expressed by Entrepreneur contributors are their own. The tampon hasn't changed much since it was invented over 80 years ago by a male doctor named Earle Haas. That might suggest the design was flawless — but ask the people who use them, and you'll hear a different story. "Period products are unreliable in critical moments," says athlete and entrepreneur Amanda Calabrese. "For athletes, that could be sporting moments, but for a mom, it could be dropping your kids off at school, or running through the airport." Instead of accepting the status quo, Calabrese and her Stanford classmate and fellow athlete, Greta Meyer, set out to rethink the product entirely. In 2019, they created Sequel, the world's first spiral tampon, engineered by and for people who actually use it. Related: How This Tampon Company Overcame Investor Knowledge Gaps and Raised $11.2 Million Engineering meets experience The idea for Sequel wasn't born out of a desire to make money — it was about solving a real problem. Calabrese and Meyer met at Stanford, where they both majored in mechanical engineering. But their connection ran deeper than academics. Both were high-level athletes: Meyer played Division I lacrosse for Stanford, while Calabrese is a six-time national champion in lifesaving, which is a whole other story. "I've competed around the world wearing nothing but a star-spangled Team USA bikini, sometimes for 10-hour events on the beach," Calabrese says. "You're running, sweating, constantly going from wet to dry, and then add your period on top of that." Meyer had similar frustrations during her time on the lacrosse team. She and her teammates, often wearing white home skirts, frequently struggled with unreliable period products. "In the locker room, they were always talking about how they could improve the experience," Calabrese recalls. One day in a shared entrepreneurship class, Meyer approached Calabrese with an idea: why not build a better period product? "She pointed out that we were both engineering students and athletes, and that this would be perfect for our Entrepreneurship project," Calabrese says. "I was immediately on board." Calabrese and Meyer were so committed to the idea that they expanded it into their senior capstone. At Stanford, capstones require a working proof of concept. So the duo went above and beyond, raising $50,000 in grant funding to continue the project after graduation and prove its potential beyond the classroom. While most college grads spent that first post-grad summer relaxing or traveling, Calabrese and Meyer traded in pool parties for manufacturing plant tours. "We spent that summer refining our idea and learning through Stanford's accelerator, StartX," Calabrese says. "We knew we'd need funding to kick off R&D, so we focused on crafting our pitch, and not long after COVID, we closed a $1 million pre-seed round to get things off the ground." Related: WNBA Legend Lisa Leslie on Building Legacy Beyond the Game From the lockeroom to the lab Starting with a clear problem gave the co-founders direction, but there were more questions to be answered before they could start developing solutions. "Now we had to ask: Why aren't these products doing their job?" Calabrese asks. "And what exactly is the job they're supposed to do?" After conferring with countless female athletes, they determined that the primary issue was what the industry calls "bypass leakage." Upon deeper reflection, the duo realized this issue was the byproduct of a design flaw. "Tampons have vertical channels that go top to bottom on the outside of the product," Calabrese explains. "This effectively funnels the fluid away from the absorbent core and down the side of the product." Recognizing the mechanical inefficiency of this outdated design, the pair came up with the concept for Sequel's masthead product: the spiral tampon. By introducing a spiral into the tampon's construction, they created a horizontal flow path alongside the existing vertical channels. This design increases surface area, promotes even absorption and helps prevent premature leaks by disrupting the downward flow. "We spent years testing the fluid mechanics behind the design," Calabrese says. "I even have a video from our dorm room where we were illustrating those concepts." Eventually, they started hand-pressing prototypes. "Greta was in a full cleanroom suit, manually applying heat and pressure to create and test each one," Calabrese recalls. The capstone goes courtside Since then, Sequel has flourished, becoming the first tampon partnership in the history of the NCAA by sponsoring Stanford athletics. They've worked with Athletes Unlimited, USL and Unrivaled. Now, the company is taking its next big step, partnering with one of the WNBA's premier teams, the Indiana Fever. The founders reached out to Fever star Lexie Hull, who attended Stanford herself, and left with an NCAA national championship and a bachelor's AND master's in management science and engineering to show for it. "Lexie remembered hearing about us as an example in one of her entrepreneurship classes," Calabrese shares. "We reached out to her to be our first WNBA ambassador, and she was so excited." The partnership offers clear financial upside for Sequel, but for Calabrese, the intangibles matter even more. "These athletes are role models," she says. "Thousands of little girls across the country look up to players on the Fever and see themselves in these athletes." She notes that the first period product someone uses is often the one they stick with for life. "Getting to work with real-life superheroes like Lexie Hull means everything to the young audience we want to reach," Calabrese says. "But beyond that, we're normalizing conversations around tampons and period care, ultimately aiming for them to be seen as essential game day gear, just like soccer cleats." After six years of research, testing, development, and navigating FDA commercial standards, Sequel is beginning to make waves in an industry that hasn't evolved in decades. "We believe Sequel can dramatically improve the experience of athletes and fans everywhere," Calabrese says. "From little girls playing softball to the moms cheering them on, everyone deserves better." With its spiral design and athlete-driven mission, Sequel isn't just redesigning a product. It's redefining the conversation around period care.
Forbes
8 minutes ago
- Forbes
Why People Leave Medicare Advantage Plans And Why It Matters To You
Over half of Medicare beneficiaries opted for Medicare Advantage plans in 2024, and the percentage is expected to climb to 60% by 2030, according to the Kaiser Family Foundation. Medicare beneficiaries can choose between Medicare Advantage plans (also known as Part C) and original Medicare. Original Medicare is coverage under Parts A and B of Medicare. Beneficiaries in original Medicare are encouraged to also have Medicare supplement (Medigap) insurance policies and Part D prescription drug policies. Medicare Advantage plans essentially bundle all that coverage into one plan and typically add benefits such as vision, dental, and hearing care. Medicare Advantage plans increased in popularity partly because of the additional benefits. Relatively healthy members of Advantage plans also tend to have lower out-of-pocket costs because they aren't paying premiums for Medigap and Part D policies. But about half of beneficiaries left their Advantage plans within five years, according to data from 2011-2020 published in the JAMA Health Forum. Some opt for a new Advantage plan while others switch to original Medicare. Before deciding to sign up for a Medicare Advantage plan, it's a good idea to know why people leave their Advantage plans. Some analysts believe the high turnover among Advantage plan members can influence how the plans are operated. If an Advantage plan's managers know most enrollees won't stick around for the long term, the plan might have less incentive to address long-term or chronic conditions of beneficiaries. The quality of an Advantage plan seems to have a significant effect on turnover. Plans that had five-star ratings lost only 23% of members after five years. While plans with four-star ratings lost over 41% of members after five years, and lower-rated plans had even higher turnover rates. Another study concluded cost wasn't a major factor in decisions to leave Advantage plans. Beneficiaries were more likely to be concerned about difficulties in accessing and receiving high-quality medical care. Another difference between original Medicare and Advantage plans is that an Advantage plan only covers care by a provider in the plan's network. In addition, some care must be approved by the plan before it will be covered. In original Medicare, the beneficiary can choose any provider who accepts Medicare and rarely needs approval from Medicare before receiving a treatment or care. Limits on the medical providers included in a plan's network as well as required approvals for treatments and care cause dissatisfaction among Advantage plan beneficiaries. The study found that beneficiaries in poor health were more likely to switch plans because of dissatisfaction about limits on providers and the need for approval of care. That finding is consistent with anecdotal reports I've heard from Medicare insurance agents over the years. They find that in the early years of retirement when people are relatively healthy, Medicare beneficiaries are happy with Medicare Advantage plans. The plans cost them less, and they don't need to visit doctors often. But when serious health conditions arise or more frequent care is needed later in retirement, people are likely to want to switch from an Advantage plan to original Medicare. Once the need for medical care increases, the limits on providers and approval requirements become more important. Generally, you can switch from an Advantage plan to original Medicare each year during open enrollment. But there's a catch. During a person's initial enrollment period for Medicare, insurers offering Medicare supplement policies are required to sell the policies without regard to a person's health history. But after the initial enrollment period, insurers generally can review an applicant's medical history and use it to decline coverage or charge higher premiums. Though a person legally can switch from an Advantage plan to original Medicare, the absence of guaranteed issue for a Medigap policy after the initial enrollment period might make the change impractical.
